L3VLUP
ProSign in

RVTY · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

RVTYLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • RVTY
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterRVTYLLY
Q3 202016 holders, $3.7bn33 holders, $14.1bn
Q4 202011 holders, $3.7bn29 holders, $17.3bn
Q1 20218 holders, $3.3bn24 holders, $23.0bn
Q2 202110 holders, $4.3bn24 holders, $27.8bn
Q3 202112 holders, $5.0bn31 holders, $29.9bn
Q4 20219 holders, $6.4bn31 holders, $34.7bn
Q1 20229 holders, $6.7bn24 holders, $35.3bn
Q2 202210 holders, $5.4bn33 holders, $42.7bn
Q3 20229 holders, $2.9bn31 holders, $43.4bn
Q4 202214 holders, $3.4bn31 holders, $46.6bn
Q1 202312 holders, $3.0bn33 holders, $44.3bn
Q2 202314 holders, $2.0bn37 holders, $59.6bn
Q3 202313 holders, $2.1bn44 holders, $67.6bn
Q4 20237 holders, $1.7bn45 holders, $73.6bn
Q1 202410 holders, $1.4bn41 holders, $95.3bn
Q2 20248 holders, $1.7bn43 holders, $110bn
Q3 20247 holders, $2.4bn45 holders, $107bn
Q4 20247 holders, $2.1bn46 holders, $93.9bn
Q1 20256 holders, $2.1bn42 holders, $98.4bn
Q2 20256 holders, $1.9bn43 holders, $93.2bn
Q3 20255 holders, $1.5bn39 holders, $86.7bn
Q4 202512 holders, $2.0bn41 holders, $123bn
Q1 20266 holders, $1.9bn39 holders, $106bn
Q2 20266 holders, $1.8bn44 holders, $132bn
RVTY

Perkinelmer Inc

Holders
12
Reported value
$2.0bn
Buyers
21
Sellers
9

Breadth +12 among 92 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUP
LLY

Eli Lilly & Co

Holders
41
Reported value
$123bn
Buyers
25
Sellers
22

Breadth +3 among 92 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2025

Among the 43 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only RVTY (2)

ExodusPoint Capital Management LP, MFS Investment Management

Only LLY (31)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Balyasny Asset Management LLC, Bridgewater Associates LP, Capital World Investors, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), GAMCO Investors Inc, Harris Associates LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Man Group PLC, Marshall Wace LLP, Moore Capital Management LP, Point72 Asset Management LP, Polen Capital Management LLC, Quantbot Technologies LP, Renaissance Technologies LLC, Rokos Capital Management LLP, and 6 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →